Onconase cytotoxic ribonuclease combined with tamoxifen: Began Phase III trial to compare survival and quality of life to therapy with a standard agent, 5-fluor

Alfacell Corp. (ACEL), Bloomfield, N.J. Product: Onconase cytotoxic ribonuclease combined with tamoxifen Indication: Advanced pancreatic cancer Status: Began Phase III trial to compare survival and q...